Veterinary Oxygen Therapy Market Report 2026

The veterinary oxygen therapy market size has grown strongly in recent years. It will grow from $1.27 billion in 2025 to $1.37 billion in 2026 at a compound annual growth rate (CAGR) of 8.3%. The growth in the historic period can be attributed to limited availability of advanced respiratory support equipment, increasing incidence of respiratory disorders in animals, growth in veterinary hospitals and clinics, rising number of surgical and anesthesia procedures, increasing awareness of animal respiratory health.

The veterinary oxygen therapy market size is expected to see strong growth in the next few years. It will grow to $1.86 billion in 2030 at a compound annual growth rate (CAGR) of 8%. The growth in the forecast period can be attributed to growth in companion animal population, rising demand for advanced intensive care services, increasing adoption of portable and homecare oxygen systems, expansion of emergency and specialty veterinary services, growing investment in veterinary critical care infrastructure. Major trends in the forecast period include rising adoption of oxygen therapy in veterinary critical care, increasing demand for portable oxygen concentrators, growing use of oxygen therapy in postoperative recovery, expansion of homecare oxygen therapy for companion animals, higher focus on respiratory disease management in animals.

The rising trend of pet adoption is expected to propel the growth of the veterinary oxygen therapy market in the coming years. The increase in pet adoption is driven by factors such as changing social trends, urbanization, and a growing number of young adults delaying parenthood. Veterinary oxygen therapy provides essential support for pets suffering from respiratory conditions, offering reassurance to pet owners by ensuring their animals receive adequate oxygen for faster and more comfortable recovery. For example, in April 2025, according to the Canadian Animal Health Institute, a Canada-based trade association, Canada was home to an estimated 7.2 million dogs and 8.2 million cats in 2024, making pets an integral part of more than half of Canadian households. Therefore, the growing trend of pet adoption is driving the veterinary oxygen therapy market.

Improved access to veterinary care is also expected to support the growth of the veterinary oxygen therapy market going forward. Veterinary care includes medical, surgical, and preventive services provided by trained professionals to promote animal welfare, treat illness and injury, safeguard public health, and strengthen the human-animal bond. Access to veterinary care has expanded due to advancements in telemedicine and the rise of mobile veterinary services, making animal healthcare more accessible to a wider population of pet owners. Veterinary oxygen therapy plays a vital role in improving survival and recovery during critical care situations by providing veterinarians with a dependable and rapid-response treatment option. This capability helps clinics, particularly those in underserved or resource-limited areas, manage respiratory emergencies more effectively and broaden the range of services they can deliver. For instance, in December 2024, according to Humane World for Animals, a U.S.-based nonprofit organization, the organization delivered 66,700 services directly to more than 16,200 pets in 2024 and supported an additional 35,200 pets through partner organizations. Therefore, improved access to veterinary care is contributing to the growth of the veterinary oxygen therapy market.

Major companies operating in the veterinary oxygen therapy market are focusing on technological innovations, such as tri-vent technology, to enhance oxygen delivery and management for animals, improve usability for veterinary professionals, and achieve better treatment outcomes for pets and livestock. Tri-vent technology incorporates a three-vent design that optimizes airflow, minimizes carbon dioxide buildup, and enhances safety by enabling more efficient oxygen delivery and exhalation control. For example, in April 2023, Pawprint Oxygen, a U.S.-based oxygen solutions provider, launched the PureVent Pet Oxygen Mask, a specialized device designed for animals experiencing respiratory distress. The mask features a triangular ergonomic design that improves oxygen flow while reducing the risk of harmful gas rebreathing. This configuration is particularly beneficial for pets with conditions such as congestive heart failure, asthma, and laryngeal paralysis. The tri-vent system allows exhaled carbon dioxide to exit without mixing with incoming oxygen, reportedly reducing carbon dioxide rebreathing by up to 80%. The PureVent Pet Oxygen Mask represents a notable advancement in veterinary oxygen therapy by providing a safer, more efficient, and more comfortable solution for oxygen administration.

Major companies operating in the veterinary oxygen therapy market are Jiangsu Yuyue Medical Equipment & Supply Co. Ltd., CAIRE Inc., Veterinary Specialty Center, Burtons Medical Equipment Ltd., Longfian Scitech Co. Ltd., CalOx Inc., Shinova Systems Co. Ltd., Vetland Animal Health Services Private Ltd., Airnetic LLC, RWD Life Science Co. Ltd., AEOLUS International Pet Products LLC, Pawprint Oxygen, New Veterinary Equipment, Avante Animal Health Inc., Vetamac Inc., Kalstein, Keyhub, Shenyang Aerti Tech, VetFlex, BMV Animal Technology, Contec Medical Systems, Jorgensen Laboratories, ON2 Solutions, Intensovet.

North America was the largest region in the veterinary oxygen therapy market in 2025. The regions covered in the veterinary oxygen therapy market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the veterinary oxygen therapy market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Tariffs have affected the veterinary oxygen therapy market by increasing costs of imported oxygen concentrators, electronic components, and flow regulation accessories. The impact is most visible in portable and high-flow oxygen concentrators used in veterinary hospitals and clinics, particularly across North America, Europe, and Asia-Pacific regions reliant on cross-border manufacturing. Higher equipment prices may limit adoption among small clinics and homecare settings. However, tariffs are encouraging local assembly, supplier diversification, and development of cost-efficient oxygen therapy solutions within regional markets.

The veterinary oxygen therapy market research report is one of a series of new reports that provides veterinary oxygen therapy market statistics, including veterinary oxygen therapy industry global market size, regional shares, competitors with a veterinary oxygen therapy market share, detailed veterinary oxygen therapy market segments, market trends and opportunities, and any further data you may need to thrive in the veterinary oxygen therapy industry. This veterinary oxygen therapy market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Veterinary oxygen therapy is a medical treatment in veterinary medicine designed to provide supplemental oxygen to animals suffering from respiratory distress, hypoxia (low blood oxygen levels), or other conditions that impair their ability to breathe effectively. The objective of oxygen therapy is to enhance the oxygen concentration in the blood, which helps vital organs function properly and supports recovery from illness or injury.

The primary products used in veterinary oxygen therapy include veterinary oxygen concentrators and associated accessories. Accessories encompass various components that aid in oxygen delivery, such as nasal cannulas, oxygen masks, humidifiers, tubing, and flow meters. Veterinary oxygen therapy is applicable to different types of animals, including small animals, large animals, and others. It is utilized in various settings, such as intensive care units (ICUs), homecare environments, postoperative care, and more. End-users of these therapies include veterinary hospitals, veterinary clinics, and other related facilities.

The veterinary oxygen therapy market consists of revenues earned by entities by providing services such as high-flow oxygen therapy, hyperbaric oxygen therapy, oxygen administration during anesthesia, standard oxygen therapy and emergency oxygen therapy. The market value includes the value of related goods sold by the service provider or included within the service offering. The veterinary oxygen therapy market also includes sales of nasal catheter, oxygen mask, oxygen chamber, oxygen tent and pure line oxygen concentrators. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.